Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Dilutive issuance
confidence 95%
filed 2026-08-12
The Company entered into securities purchase agreements on August 11, 2026, to issue 2,000,000 ordinary shares at $0.90 per share for gross proceeds of $1.8 million in a private investment in public equity transaction under Regulation S. This is an unregistered equity issuance that will dilute existing shareholders, with closing expected August 27, 2026. The transaction includes a material insider purchase by Chairman Zheng Jiahua of 500,000 shares.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Turn Therapeutics issued a press release on August 12, 2026 announcing financial and operating results for the quarter ended June 30, 2026, including consolidated statements of operations and selected balance sheet data. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The filing includes quarterly financial metrics (operating expenses, net loss, loss per share, cash position) and is material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-08-12
Item 1.01
OS Therapies entered into a securities purchase agreement on August 10, 2026, to issue senior secured convertible promissory notes totaling up to $10,000,000 in a private placement, with the initial tranche of $5,000,000 already closed. The offering includes common stock, pre-funded warrants, and five-year warrants, creating substantial dilution to existing shareholders through unregistered sales of equity securities under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-08-12
Item 5.07
Stockholders approved an amendment to extend the business combination termination date from August 12, 2026 to August 12, 2027, with board discretion to extend monthly, at the August 6, 2026 annual meeting. The Extension Amendment Proposal and Adjournment Proposal each received overwhelming approval (5,913,418 FOR votes vs. 999 AGAINST). Additionally, 215,488 shares were tendered for redemption.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-12
Ticketplus Ltd. completed an initial public offering on August 10, 2026, issuing 1,875,000 ordinary shares at $8.00 per share for $15 million in gross proceeds, followed by partial exercise of a 45-day over-allotment option on August 12, 2026, for an additional 258,814 shares generating approximately $2.07 million in gross proceeds. This is a material equity issuance event that dilutes existing shareholders and raises capital for the company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
SUNation Energy issued a press release on August 12, 2026 announcing financial results for Q2 2026 (quarter ended June 30, 2026), disclosing consolidated revenue of $8.2 million, gross profit of $2.1 million, operating loss of $3.18 million, and net loss of $3.34 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a press release announcing Cyngn's financial results for Q2 2026 (six months ended June 30, 2026), filed under Item 2.02 Results of Operations and Financial Condition. The disclosure includes detailed consolidated statements of operations, balance sheets, and cash flows, along with narrative discussion of revenue ($249k YTD), net loss ($12.8M YTD), and cash position ($39.7M). This is a standard earnings release that would materially affect a reasonable investor's assessment of the company's financial condition and operating performance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-12
EX-99.1
SAIHEAT Limited entered into a merger agreement with Canopy Wave Inc. (a Delaware corporation) on August 10, 2026, whereby SAIHEAT will acquire Canopy Wave for 3.3 million ordinary shares valued at approximately $60 million, with a concurrent PIPE investment of $4.5 million. The transaction constitutes a material acquisition and change of control, with the sellers expected to hold a majority of the company's economic interests and voting power post-closing, and the company to be renamed Canopy Wave Holdings Inc. and relisted under a new ticker symbol, subject to shareholder approval at an extraordinary general meeting scheduled for August 26, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
New Concept Energy reported Q2 2026 financial results on August 10, 2026, disclosing revenue of $41,000 and a net loss of $66,000 for the quarter, along with condensed consolidated balance sheets and statements of operations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-12
Item 1.01
The filing discloses entry into a third amendment to a Merger Agreement, extending the outside date from August 31, 2026 to October 31, 2026. This is a material amendment to an existing M&A transaction that affects the timeline and conditions of the merger, making it a material M&A activity event under Item 1.01.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Ashford Hospitality Trust, Inc. (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The filing includes consolidated balance sheets, statements of operations, and detailed financial highlights including net income, EBITDA, and per-share metrics, which are hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-08-12
EX-99.1
This is a formal Report of Voting Results disclosing the outcomes of High Tide Inc.'s annual general and special meeting of shareholders held on August 11, 2026. The document reports voting results on four matters: (1) re-appointment of Davidson & Company LLP as auditor (99.47% for); (2) fixing the number of directors at five (97.92% for); (3) election of five director nominees (all with >97% support); and (4) ratification of a restated shareholder rights plan (91.07% for). This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 Continuous Disclosure Obligations.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-08-12
EX-99.1
This is a news release announcing the voting results from High Tide's annual general and special meeting of shareholders held on August 11, 2026. The exhibit discloses detailed vote tallies for the election of five directors (Harkirat Grover, Christian Sinclair, Arthur Kwan, Menashe Kestenbaum, and Kathleen Skerrett), fixing the board at five members, appointment of Davidson & Company LLP as auditors, and approval of an Amended and Restated Shareholder Rights Plan. These are core shareholder governance matters whose outcomes materially affect the registrant's governance structure and would affect a reasonable investor's assessment.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-12
EX-99.1
This is a news release dated August 12, 2026, announcing "2026 Second Quarter Financial Results and Operating Highlights" for First Mining Gold Corp. The release explicitly states that "financial statements and management's discussion and analysis ('MD&A') are available" and reports Q2 2026 results for the quarter ended June 30, 2026. While the release emphasizes operational highlights (environmental approvals, Indigenous agreements, exploration results, and asset transactions), it is fundamentally structured as a quarterly earnings announcement disclosing financial results alongside operational context, making it an earnings_release rather than a purely operational disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
This is a quarterly earnings release for Q2 2026 (ended June 30, 2026) disclosing consolidated financial results including adjusted EPS of R$0.33 versus R$0.57 in 2Q25, adjusted EBITDA of R$3,503 million (down 3.2% YoY), and adjusted net income of R$1,150 million (down 41.2% YoY). The document contains a full income statement, balance sheet, cash flow statement, and detailed operational metrics typical of a quarterly results announcement. Material to investors as it shows significant earnings decline and operational challenges including revenue pressures, cost inflation, and higher funding costs.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-12
Vale announces advancement of the Salobo Coarse Particle Flotation (CPF) project to execution phase with a revised start-up timeline of 1H2028 (one year ahead of schedule), expected to add 6 million tonnes of annual ore processing capacity and increase copper production by ~30,000 tonnes annually. The project involves a US$215 million capex (reduced from US$225-275 million) with US$40 million funding from Wheaton Precious Metals, representing a material operational and capital investment milestone within Vale's copper growth strategy targeting 700,000 tonnes per year by 2035. This is a discrete operational/strategic milestone rather than a periodic report, earnings release, or other classified event type.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-12
Item 7.01
JLL Income Property Trust's Board declared a monthly dividend of $0.0525 per share for August 2026, payable on or around August 26, 2026. The press release explicitly announces this distribution declaration, which is a routine but material disclosure for a REIT. The company also notes the transition from quarterly to monthly distributions in March 2026, providing context on the distribution policy change.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Altimmune issued a press release on August 12, 2026 announcing financial results for Q2 2026 ended June 30, 2026, including consolidated balance sheets and statements of operations. The disclosure includes quarterly financial metrics (R&D expenses of $18.7M, G&A expenses of $7.6M, net loss of $22.8M), cash position of $519M, and material clinical milestones (PERFORMA Phase 3 initiation, RECLAIM Phase 2 positive data, RESTORE Phase 2 enrollment completion). This is a standard quarterly earnings release with financial statements and business updates furnished as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a news release announcing North American Construction Group's Q2 2026 financial results for the quarter ended June 30, 2026. The exhibit discloses quarterly revenue of $400.963 million (reported) and $456.082 million (combined), adjusted EBITDA of $93.5 million, net income of $9.4 million, and free cash flow of $23.0 million, along with a raised full-year 2026 combined revenue guidance to $1.6–$1.8 billion. The company also declared a quarterly dividend of $0.12 per share. This is a classic earnings release event material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-12
Item 5.02
The Board appointed Aaron Alt as an independent director effective August 14, 2026, and also appointed him to the Audit and Finance Committee. This is a clear executive appointment event. While the disclosure mentions that Mr. Alt will participate in standard non-employee director compensation arrangements, the principal disclosed action is the appointment itself, not a new or modified compensation arrangement, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-08-12
Item 4.02
The CFO concluded on August 7, 2026 that previously issued unaudited condensed consolidated financial statements for multiple quarterly periods should no longer be relied upon due to errors in the weighted average number of common shares outstanding and related basic and diluted net loss per share calculations. The company is filing amended 10-Q/A forms to restate these amounts across multiple periods (Q1 2025, Q2 2025, Q3 2025, and Q1 2026), and management identified a material weakness in internal controls over financial reporting related to these computations. This is a classic financial restatement disclosure under Item 4.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Capstone Holding Corp. issued a press release on August 12, 2026, announcing Q2 2026 financial results with revenue of $21.5 million (up 67% YoY), gross profit of $6.0 million (up 92% YoY), and Stone Business Adjusted EBITDA of $2.0 million, along with reaffirmed full-year 2026 guidance and an investor presentation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a standard earnings release disclosing quarterly and six-month financial results for Neonode Inc. for the periods ended June 30, 2026. Item 2.02 explicitly states the company "reported its earnings for the three and six months ended June 30, 2026" with the full press release attached as Exhibit 99.1, containing detailed financial statements, revenue analysis, and CEO commentary on operational performance. This is material to investors as it provides comprehensive financial performance data including revenue trends (20.4% decline in Q2), operating losses, cash position, and strategic updates on the company's licensing business transformation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Monopar's second quarter 2026 financial results, including net loss of $5.3 million (vs. $2.5 million in Q2 2025), R&D and G&A expenses, cash position of $134.3 million, and interest income. The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes both financial metrics and material business updates regarding ALXN1840's NDA rolling submission and regulatory progress.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-12
Item 5.02
The disclosure centers on the Compensation Committee's approval of a stock option grant to Randy Gilbert, the CEO/CFO, under the 2021 Stock Incentive Plan. The grant of 100,000 shares at $4.51 per share with a four-year vesting schedule is a compensatory arrangement for a named executive officer, fitting the exec_compensation category. This is material as equity grants to senior executives affect investor assessment of compensation practices and dilution.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 12, 2026. The press release discloses quarterly financial results including revenue ($23.7M, up 19%), net income ($0.3M or $0.01 per share vs. prior year loss), Adjusted EBITDA ($1.1M, up 128%), and raises full-year 2026 revenue guidance to 14-16% growth. The disclosure is material to investors as it reports actual financial performance and updates forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Mannatech issued a press release on August 12, 2026 announcing financial and operating results for the second quarter ended June 30, 2026, disclosing net sales of $26.7 million, net income of $1.0 million ($0.53 per diluted share), and other key financial metrics. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-08-12
Item 5.02
The Board formally accepted the retirements of two directors, James R. Brown, Sr. and Panos Lazaretos, effective immediately on August 6, 2026, following a Board review that concluded the designating shareholder had breached agreements and that the directors' actions were adverse to the Company and violated policies and regulations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a standard quarterly earnings release for Q2 2026 disclosing financial results (net loss of $4.3 million, cash position of $17.1 million) and operational updates on the NEPHRO CRRT clinical trial (75% enrollment) and regulatory developments (KDIGO guideline inclusion). The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings releases. Material to investors assessing the company's financial condition and clinical progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Sky Harbour Group Corporation issued a press release on August 12, 2026, announcing its financial results for the three and six months ended June 30, 2026, including consolidated revenues, operating cash flow, liquidity metrics, and adjusted EBITDA. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The filing includes specific financial highlights such as 50% revenue growth in Q2 2026 versus Q2 2025 and the company's first quarter of positive operating cash flow, making this material to investors' assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Omeros Corporation issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026. The disclosure includes detailed quarterly financial metrics (net income of $13.2 million or $0.18 per share for Q2 2026), revenue figures for YARTEMLEA ($32.2 million gross, $28.5 million net), cash position ($132.0 million), and operating results. This is a standard earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
SeaStar Medical issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $0.6 million (82% increase vs. Q2 2025), net loss of $3.7 million, and cash position of $7.0 million. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The filing includes detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-12
Item 1.01
Sky Harbour Group entered into a Stock Purchase Agreement on August 10, 2026, to sell 4,000,000 shares of Class A common stock at $10.00 per share in a registered direct offering, closing on August 12, 2026, and raising $40.0 million in gross proceeds. While technically a registered offering (not unregistered), the disclosure of a material equity issuance with dilutive impact to existing shareholders is most closely aligned with dilutive_issuance in the taxonomy. The 90-day lock-up provision and concurrent secondary transactions by Boston Omaha Corporation further underscore the capital-raising nature of this transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Daily Journal Corporation announced financial results for the three and nine months ended June 30, 2026 via press release furnished as Exhibit 99.1. The disclosure includes consolidated revenue ($27.0M for Q3, $69.2M for nine months), operating income, net loss, and earnings per share, along with detailed segment performance and balance sheet data. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Planet 13 announced Q2 2026 financial results via press release on August 12, 2026, disclosing revenue of $22.9 million, net loss of $5.6 million, and adjusted EBITDA loss of $0.5 million. The filing explicitly states "On August 12, 2026, Planet 13 Holdings Inc. (the "Company") announced via press release its results for the second quarter ended June 30, 2026" and furnishes the press release as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
BioCardia issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed consolidated statements of operations and selected balance sheet data. The disclosure includes quarterly net loss, operating expenses, cash position, and per-share metrics—all hallmarks of an earnings release. Item 2.02 explicitly covers "Results of Operations and Financial Condition," and the attached Exhibit 99.1 is the formal press release announcing Q2 2026 financial results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Crown Crafts issued a press release on August 12, 2026 announcing financial results for the first quarter of fiscal 2027 ended June 28, 2026, with net sales of $16.8 million (up from $15.5 million) and net income of $2.1 million or $0.19 per share (versus a net loss of $1.1 million in the prior year).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-12
Item 5.07
Results of the 2026 Annual Meeting held on August 10, 2026 disclosed the voting outcomes for three proposals: election of two Class III directors (Ixchell C. Duarte and Tatiana G. Ferreira), approval of the Amended and Restated 2021 Incentive Plan, and ratification of KPMG LLP as independent auditor.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-12
Item 5.02
Stockholders approved the Amended and Restated 2021 Incentive Plan, which increases available shares from 1.2 million to 2.45 million for equity awards to directors, officers, and employees.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Reviva disclosed Q2 2026 financial results (ended June 30, 2026) via press release, reporting a net loss of $2.4 million for the quarter and a cash position of $19.9 million as of quarter-end, along with recent clinical development milestones.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-12
Item 8.01
The filing announces a monthly cash dividend of $0.10 per share declared by the Board of Directors for August 2026, payable September 29, 2026. This is a routine but material dividend distribution disclosure typical of a REIT, which the Company states it must distribute at least 90% of REIT taxable income annually to maintain REIT status. The announcement is the primary purpose of the 8-K filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
M-tron Industries disclosed its financial results for the three and six months ended June 30, 2026, reporting Q2 2026 revenue of $15.1 million (up 13.8%), net income of $1.9 million (up 19.9%), and adjusted EBITDA of $3.4 million (up 40.6%), along with a 37.2% increase in backlog to $84.0 million. The company also announced a conference call to discuss the results.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-12
Item 5.02
The filing discloses both a departure (Riley McCormack's resignation from the Board) and an appointment (Paul Carreiro's election to the Board on the same date). While both events occurred, the appointment is the principal forward-looking action—Carreiro was elected to fill the vacancy and will serve until the next shareholder meeting. The appointment of a new director to the Board is material to investors' assessment of governance and leadership continuity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-12
EX-99.1
Bullish announced the launch of tokenized equity trading on its GFSC-regulated exchange, with the first trades of its own tokenized shares (BLSH) executed and settled in USD stablecoin. This is a material operational and strategic milestone—the first tokenized equity trading on a regulated digital asset exchange—that demonstrates progress toward Bullish's broader tokenization infrastructure strategy and the pending Equiniti acquisition. While the announcement references the acquisition, the primary disclosed event is the operational launch of a new trading capability, not the M&A activity itself.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
OptimizeRx issued a press release on August 12, 2026 announcing Q2 2026 financial results, including revenue of $20.5 million, net loss of $(0.7) million, and adjusted EBITDA of $4.9 million, along with reaffirmed full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 70%
filed 2026-08-12
Item 5.02
Edward Stelmakh departed as Chief Financial & Strategy Officer effective December 31, 2026, with a separation agreement providing $450K salary continuation, $247.5K bonus, COBRA, and advisory services through 2027. Concurrent appointments of D'Silva as CFO and Favazza as Chief Accounting Officer effective January 1, 2027 establish a succession plan.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Avino's Q2 2026 unaudited condensed interim consolidated financial results, with detailed financial highlights including revenues of $26.8 million (up 23% YoY), net income of $10.9 million (up 281% YoY), and diluted EPS of $0.06 (up 200% YoY). The document explicitly states "AVINO REPORTS Q2 2026 FINANCIAL RESULTS" and presents comprehensive operating and financial performance metrics for the quarter, making it a classic earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
GEE Group Inc. issued a press release on August 12, 2026 announcing consolidated financial results for the fiscal 2026 third quarter and year-to-date periods ended June 30, 2026, reporting net income from continuing operations of $566 thousand for Q3 (versus a loss in the prior year), improved gross margins of 39.9% versus 35.4%, and adjusted EBITDA of $570 thousand.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-08-12
EX-99.1
Farmmi received a Nasdaq deficiency notification on August 11, 2026, for failure to maintain the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has 180 calendar days (until February 8, 2027) to regain compliance or face potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, as it notifies investors of a material threat to continued listing on Nasdaq.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-12
EX-99.1
CLINUVEL announced advancement of its VLRX-L controlled-release injectable peptide platform following promising preclinical results, with candidate formulations selected for further preclinical studies in Q1 2027 and manufacturing scale-up being scoped. This is a material operational/R&D milestone disclosing progress on a key platform technology, but does not fit discrete event categories (not an earnings release, M&A, impairment, or litigation); it is a strategic product-development update that would affect investor assessment of the company's pipeline and technical capabilities.
View raw filing on EDGAR →